Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation

被引：14
|
作者：
Neumann, Martin [1 ]
Blau, Igor W. [1 ]
Burmeister, Thomas [1 ]
Tietze-Buerger, Carola [1 ]
Blau, Olga [1 ]
Gerbitz, Armin [1 ]
Uharek, Lutz [1 ]
Thiel, Eckhard [1 ]
机构：
[1] Univ Hosp Berlin, Charite, Dept Hematol & Oncol, D-12203 Berlin, Germany
来源：
ANNALS OF HEMATOLOGY | 2011年 / 90卷 / 08期
关键词：
Intrathecal; DLI; Leukemic meningeosis; Extramedullary relapse; Adoptive cell therapy; CNS; BONE-MARROW-TRANSPLANTATION; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; EXTRAMEDULLARY RELAPSE; CHEMOTHERAPY; INFUSION; DISEASE; SITES; CNS;
D O I：
10.1007/s00277-011-1171-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Extramedullary relapses after allogeneic stem cell transplantation, especially within the central nervous system (CNS), are not only difficult to treat but also associated with poor outcome. Although the graft-versus-leukemia (GvL) effect is nowadays accepted and well documented, it remains controversial whether one can make use of GvL effects in immunological-restricted areas ("sanctuary sites") like the central nervous system. Here, we present data of three hematological patients suffering from isolated CNS relapse of CML or AML after allogeneic stem cell transplantation. Patients received in addition to chemotherapy intrathecal infusions of donor lymphocytes by CD14 depletion of peripheral blood mononuclear cells from the correspondent allogeneic donor. Referring to an observation period of maximum 17 months no immediate or delayed side effects could be detected.
引用
收藏
页码：911 / 916
页数：6
相关论文
共 50 条
  • [21] Core information reported to donor centers after allogeneic stem cell transplantation
    Laursen, HB
    Lanther, T
    Holder, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 108 - 108
  • [22] Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplantation: A Retrospective Analysis
    Escamilla Gomez, Virginia
    Martin Rodriguez, Francisco
    Perez Ortega, Laura
    Calderon Cabrera, Cristina
    Mingot Castellano, Eva Maria
    Martinez Cibrian, Nuria
    Reguera Ortega, Juan Luis
    Rodriguez Torres, Nancy
    Espigado Tocino, Ildefonso
    Perez Simon, Jose Antonio
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 201 - 202
  • [23] Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation
    Hardy, Nancy M.
    Fellowes, Vicki
    Rose, Jeremy J.
    Odom, Jeanne
    Pittaluga, Stefania
    Steinberg, Seth M.
    Blacklock-Schuver, Bazetta
    Avila, Daniele N.
    Memon, Sarfraz
    Kurlander, Roger J.
    Khuu, Hahn M.
    Stetler-Stevenson, Maryalice
    Mena, Esther
    Dwyer, Andrew J.
    Levine, Bruce L.
    June, Carl H.
    Reshef, Ran
    Vonderheide, Robert H.
    Gress, Ronald E.
    Fowler, Daniel H.
    Hakim, Frances T.
    Bishop, Michael R.
    BLOOD, 2012, 119 (12) : 2956 - 2959
  • [24] Clinical scale production of HSV-tk/LNGFR transduced allogeneic T-lymphocytes for treatment of leukemic relapse after allogeneic stem cell transplantation
    Davis, JG
    Garin, M
    Marktel, S
    Miller, A
    Elliston, D
    Melo, JV
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2002, 29 : S42 - S42
  • [25] Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation
    Winkler, Julia
    Tittlbach, Hannes
    Schneider, Andrea
    Vasova, Ingrid
    Strobel, Julian
    Herold, Susanne
    Maas, Stefanie
    Spriewald, Bernd M.
    Repp, Roland
    Kordelas, Lambros
    Mach, Michael
    Wolff, Daniel
    Edinger, Matthias
    Mackensen, Andreas
    Winkler, Thomas H.
    BLOOD ADVANCES, 2024, 8 (10) : 2373 - 2383
  • [26] Epstein -Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation
    Takamatsu, Hiroyuki
    Araki, Raita
    Nishimura, Ryosei
    Yachie, Akihiro
    Espinoza, J. Luis
    Okumura, Hirokazu
    Yoshida, Takashi
    Kuzushima, Kiyotaka
    Nakao, Shinji
    JOURNAL OF CLINICAL VIROLOGY, 2016, 80 : 82 - 86
  • [27] Large granular lymphocytes (LGL) expansion after allogeneic stem cell transplantation.
    de Soria, VGG
    Aguado, B
    de la Cámara, R
    Loscertales, J
    Granda, A
    Arranz, R
    Figuera, A
    Aláez, C
    Blázquez, C
    Fernández-Rañada, JM
    BLOOD, 2002, 100 (11) : 449B - 449B
  • [28] GRAFT-VERSUS-HOST DISEASE AFTER DONOR LYMPHOCYTES INFUSIONS IN PATIENTS WITH RELAPSED HEMATOLOGICAL MALIGNANCIES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Bogdanov, R.
    Mendeleeva, L.
    Galtseva, I.
    Kuzmina, L.
    Pokrovskaya, O.
    Parovichnikova, E.
    Savchenko, V.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S294 - S295
  • [29] Second allogeneic stem cell transplantation for osteomyelofibrosis relapsed after initial allogeneic stem cell transplantation
    Klyuchnikov, E.
    Ayuk, F.
    Bacher, U.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S262 - S262
  • [30] Timing of donor lymphocyte apheresis for immunotherapy after allogeneic blood stem cell transplantation
    Nowak-Hamau, S
    Krug, E
    Maccari, B
    Schmitt, A
    Reinhardt, P
    Kubanek, B
    Wiesneth, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S112 - S112
12345